P544The importance of contractile reserve when assessing asymptomatic patients with aortic stenosisP545Determinants of secondary mitral regurgitation in patients with aortic stenosis and preserved ejection fractionP546Exercise physiology in patients with mitral annular calcificationP547Evaluation of left atrial strain in patients with rheumatic mitral stenosisP548Impact of mitral regurgitation on impaired alveolar-capillary membrane diffusion in heart failure with reduced ejection fractionP549Edge-to-edge-repair in patients with dilated cardiomyopathy and secondary mitral regurgitation: acute effect on annular geometryP550Changes in the management of functional mitral regurgitation in the last 8 years in a tertiary referral hospitalP551Percutaneous closure of periprosthetic paravalvular leaks under echocardiographic guidance: establishing an alternative to reoperation?P552Clinical profile and predictors of mortality in infective endocarditis with neurologic complicationsP553TAVI, arterial stiffness and ventricular-arterial couplingP554Low contrast media CT angiography prior to transcatheter aortic valve implantation procedureP555Hemodynamic and prognostic impact of permanent pacemaker implantation following transcatheter aortic valve implantationP556Impact of transfemoral aortic valve implantation or surgical aortic valve replacement on right ventricular function in the early postprocedural phaseP557Effects of atrial fibrillation in patients undergoing mitral valve repair with the mitraclip system:one-year outcomes from the GRASP registryP558Who will not benefit from cardioversionP559Is there residual mechanical dysynchrony after initial IEGM optimization in cardiac resynchronization patients?P560Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunctionP561Improvement of left ventricular ejection fraction is correlated with serum markers of extracellular matrix fibrosis in dilated cardiomyopathyP5622D-radial strain as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriersP563Long term vigorous exercise is well tolerated in hypertrophic cardiomyopathyP564Left atrial volume and not diameter is the main determinant of atrial fibrillation in patients with hypertrophic cardiomyopathyP565Assessment of papillary muscle mass, apical displacement and mitral valve function in children and young adults with hypertrophic cardiomyopathy using three dimensional echocardiographyP566Combining tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain to predict outcome of patients with light-chain cardiac amyloidosisP567Left and right ventricular dysfunction in patients submitted to chemotherapy with anthracyclines - predictive value of myocardial deformation imagingP568Echocardiography outcome monitoring of hypertensive patients with diastolic dysfunction under doxorubicin therapy

Autor: AL. Pop-Moldovan, AC. Gomes, D. Liu, N. Joseph, M. Rosca, LA. Dejgaard, G. Santambrogio, S. Wisniowska-Smialek, S M R Amorim, J. Ljubas Macek, M. Leitman, AM. Caggegi, A. Mas-Stachurska, M. Drakopoulou, A. Annoni, E. Sciatti, M. Braga, AI. Azevedo, M. Ruiz Ortiz, L. Faber, D. Fina, FA. Castro, G. Pressman, JM. Bantu-Bimbi, JJ. Van Zalen, S. Badiani, L. Hart, A. Marshall, N. Patel, G. Lloyd, L. Jahjah, D. Schulze, T. Tran, T. Pepersack, JL. Vandenbossche, P. Unger, Y. Topilsky, E. Donal, O. Azevedo, M. Lourenco, M. Fernandes, I. Oliveira, A. Lourenco, G. Santos, V. Labate, A. Gasperetti, PL. Laforgia, F. Bandera, E. Alfonzetti, M. Guazzi, W. Scholtz, A. Graw, N. Bogunovic, Z. Dimitriadis, S. Scholtz, J. Boergermann, J. Gummert, D. Horstkotte, D. Mesa, M. Delgado, G. Gutierrez Ballesteros, C. Aristizabal Duque, J. Fernandez Cabeza, E. Duran, C. Ferreiro, J. Sanchez Fernandez, J. Suarez De Lezo, P. Braga, A. Rodrigues, L. Santos, B. Melica, J. Ribeiro, F. Sampaio, R. Fontes-Carvalho, A. Dias, V. Gama Ribeiro, H. Nascimento, L. Flores, V. Ribeiro, F. Melao, C. Sousa, F. Macedo, P. Dias, MJ. Maciel, E. Vizzardi, I. Bonadei, F. Platto, M. Metra, A. Formenti, ME. Mancini, G. Pontone, D. Andreini, L. Fusini, M. Muratori, S. Mushtaq, M. Guglielmo, M. Pepi, K. Toutouzas, K. Stathogiannis, A. Michelongona, G. Latsios, A. Synetos, G. Trantalis, S. Sideris, G. Lazaros, D. Tousoulis, M. Cladellas, M. Ble, B. Vaquerizo, N. Farre, L. Molina, M. Gomez, R. Millan, J. Marti, S. Scandura, P. Capranzano, S. Mangiafico, G. Ronsivalle, M. Chiaranda', S. Giaquinta, A. Popolo Rubbio, S. Farruggio, S. Buccheri, S. Imme', G. Castania, ME. Di Salvo, D. Capodanno, C. Tamburino, V. Tyomkin, E. Peleg, T. Fuchs, Z. Gabara, Z. Vered, V. Reskovic Luksic, M. Pasalic, B. Pezo Nikolic, M. Brestovac, J. Separovic Hanzevacki, J. Rodrigues, M. Campelo, B. Moura, E. Martins, J. Silva-Cardoso, P. Rubis, L. Khachatryan, A. Karabinowska, P. Faltyn, E. Dziewiecka, B. Biernacka-Fijalkowska, A. Lesniak-Sobelga, M. Kostkiewicz, P. Podolec, A. Peritore, P. Vallerio, F. Spano', L. Occhi, R. Facchetti, E. Manfredini, F. Turazza, A. Moreo, C. Giannattasio, TF. Haland, OH. Lie, M. Ribe, IS. Leren, T. Edvardsen, KH. Haugaa, L. Mandes, A. Calin, CC. Beladan, R. Enache, A. Mateescu, C. Baicus, C. Ginghina, BA. Popescu, L. Li, M. Craft, L. Mill, C. Erickson, S. Kutty, K. Hu, S. Herrmann, M. Cikes, G. Ertl, F. Weidemann, S. Stoerk, P. Nordbeck, LR. Lopes, M. Correia, AG. Ferreira, H. Mansinho, H. Pereira, M. Trofenciuc, DA. Darabantiu, M. Puschita, RM. Christodorescu

Publikováno v: European Heart Journal – Cardiovascular Imaging. 17:ii95-ii102

Asymptomatic patients may exhibit symptoms during objective exercise testing, but whether symptoms are due to the obstructively of the valve (typified by the mean gradient) or underlying ventricular function remains unknown. While the mean gradient i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5263b08a774ead666122a0c0cb0bdf16
https://doi.org/10.1093/ehjci/jew248.001

[Recognize the frailty: A challenge in general medicine]

Autor: T, Pepersack

Publikováno v: Revue medicale de Bruxelles. 37(4)

Frailty is the most problematic expression of population ageing. It is a state of vulnerability to poor resolution of homoeostasis after a stressor event and is a consequence of cumulative decline in many physiological systems during a lifetime leadi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::28fc6175ccdc359a05456455829fc700
https://pubmed.ncbi.nlm.nih.gov/28525239

PS1517 MILD COGNITIVE IMPAIRMENT, HYPOALBUMINEMIA, HIGH CRP AND GASTRO-INTESTINAL ULCER: 4 MARKERS OF FRAILTY WHICH IDENTIFY OLDER PATIENTS WITH MALIGNANT HEMOPATHIES WHO DON’T BENEFIT FROM CHEMOTHERAPY

Autor: D. Bron, Vincent Thibaud, T. Lamy de la Chapelle, Michel Delforge, L. Dal Lago, T. Pepersack, L. Deneve, Stéphanie Dubruille, H. Wildiers, Cindy Kenis, Cindy Borghgraef

Publikováno v: HemaSphere. 3:699

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b9d0a0cf12cd41310ac827cddab4f17a
https://doi.org/10.1097/01.hs9.0000564328.87522.a2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Non valvular atrial fibrillation: the place of the new anticoagulants]

Autor: T, Pepersack

Publikováno v: Revue medicale de Bruxelles. 36(4)

Atrial fibrillation (AF) increases the risk of mortality and stroke. The prevention of these complications is based on oral anticoagulants that are more efficient than salycilates. As compared with antivitamins K agents, new oral anticoagulants are p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::29b8e31bbbec89a5b934262446d54960
https://pubmed.ncbi.nlm.nih.gov/26591325